• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment


20.5500 USD 0.2100 1.03%

As of 20:10:00 ET on 04/17/2014.

Snapshot for QIAGEN NV (QGEN)

Open: 20.4700 Day's Range: 20.3300 - 20.7400 Volume: 1,822,217
Previous Close: 20.3400 52wk Range: 18.3000 - 24.8200 1-Yr Rtn: -0.19%

Stock Chart for QGEN

No chart data available.
  • QGEN:US 20.5500
  • 1D
  • 1M
  • 1Y
Interactive QGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QGEN

Current P/E Ratio (ttm) 33.9851
Estimated P/E(12/2014) 18.8015
Relative P/E vs. SPX 1.9762
Earnings Per Share (USD) (ttm) 0.6047
Est. EPS (USD) (12/2014) 1.0930
Est. PEG Ratio 1.6618
Market Cap (M USD) 4,926.40
Shares Outstanding (M) 239.73
30 Day Average Volume 1,274,226
Price/Book (mrq) 1.8148
Price/Sale (ttm) 3.7370
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QGEN

QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Peer M SchatzCEO/Managing DirectorRoland SackersCFO/Managing Director
Dietrich HauffeSenior VP:Life Sciences BusDouglas LiuSenior VP:Global Operations
More Company Profile & Key Executives for QGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil